Market Cap 549.17M
Revenue (ttm) 482.04M
Net Income (ttm) 860,000.00
EPS (ttm) N/A
PE Ratio 0.00
Forward PE 26.38
Profit Margin 0.18%
Debt to Equity Ratio 0.00
Volume 1,380,700
Avg Vol 2,401,664
Day's Range N/A - N/A
Shares Out 126.83M
Stochastic %K 79%
Beta 1.79
Analysts Strong Sell
Price Target $6.00

Latest News on ORGO

Organogenesis Commends Final LCDs

Nov 15, 2024, 9:25 AM EST - 5 months ago

Organogenesis Commends Final LCDs


Organogenesis Shares ReNu® Program Update

Aug 8, 2024, 4:04 PM EDT - 9 months ago

Organogenesis Shares ReNu® Program Update